Dose escalation study of docetaxel and nedaplatin in patients with relapsed or refractory squamous cell carcinoma of the esophagus pretreated using cisplatin, 5-fluorouracil, and radiation

International Journal of Clinical Oncology

Volumn 11, Issue 6, 2006, Pages 454-460

  Yoshioka, Takashi ^a   Sakayori, Masato ^a   Kato, Shunsuke ^a   Chiba, Natsuko ^a   Miyazaki, Shukichi ^b   Nemoto, Kenji ^b   Shibata, Hiroyuki ^a   Shimodaira, Hideki ^a   Ohtsuka, Kazunori ^a   Kakudo, Yuichi ^a   Sakata, Yuh ^c   Ishioka, Chikashi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Misawa City Hospital   (Japan)

Author keywords

Definitive chemoradiation; Docetaxel; Dose escalation study; Esophageal cancer; Nedaplatin

Indexed keywords

CISPLATIN; DEXAMETHASONE; DOCETAXEL; FLUOROURACIL; NEDAPLATIN; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INJECTION SITE REACTION; LEUKOPENIA; MALE; MAXIMUM TOLERATED DOSE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; PATIENT COMPLIANCE; PREMEDICATION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SENSORY NEUROPATHY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANOPLATINUM COMPOUNDS; REMISSION INDUCTION; SALVAGE THERAPY; TAXOIDS;

EID: 33845749675     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0610-5     Document Type: Article

References (33)

1. JM Muller H Erasmi M Stelzner 1990 Surgical therapy of oesophageal carcinoma Br J Surg 77 845 857
2. N Ando S Ozawa Y Kitagawa 2000 Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years Ann Surg 232 225 232
3. A Herskovic K Martz M Al-Sarraf 1992 Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 1593 1598
4. JS Cooper MD Guo A Herskovic 1999 Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01) JAMA 281 1623 1627
5. A Ohtsu N Boku K Muro 1999 Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus J Clin Oncol 17 2915 2921
6. A Chan A Wong 1999 Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma? Int J Radiat Oncol Biol Phys 45 265 270
7. S Hironaka A Ohtsu N Boku 2003 Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T2-3NanyM0 squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 57 425 433
8. TN Walsh N Noonan D Hollywood 1996 A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462 467
9. JF Bosset M Gignoux JP Triboulet 1997 Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus N Engl J Med 337 161 167
10. SG Urba MB Orringer A Turrisi 2001 Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma J Clin Oncol 19 305 313
11. KJ Scanlon EM Newman Y Lu 1986 Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells Proc Natl Acad Sci USA 83 8923 8925
12. JE Byfield 1990 Combined modality infusional chemotherapy with radiation JJ Lokich Cancer Chemotherapy by infusion (2nd edn) Percepta Chicago 521 551
13. CMM Araujo L Souhami RA Gil 1991 A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus Cancer 67 2258 2261
14. T Conroy PL Etienne A Adenis 1996 Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma J Clin Oncol 14 164 170
15. F Lordick C von Schilling H Bernhard 2003 Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer Br J Cancer 89 630 633
16. K Muro T Hamaguchi A Ohtsu 2004 A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer Ann Oncol 15 955 959
17. I Ringel SB Horwitz 1991 Studies with RP56976 (Taxotere): a semisynthetic analogue of Taxol J Natl Cancer Inst 83 288 291
18. Totani T, Aono K, Komura M (1986) Synthesis of (glycolato-o, o′) diammine platinum (II) and its related complexes. Chem Lett 429-432
19. T Taguchi A Wakui K Nabeya 1992 A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers Jpn J Cancer Chemother 19 483 488
20. HJ Burstein J Manola J Younger 2000 Docetacel administered on a weekly basis for metastatic breast cancer J Clin Oncol 18 1212 1219
21. H Fukuda N Saijyo 2001 National Cancer Institute - Common Toxicity Criteria (NCI-CTC version 2.0, April 30, 1999) - The second version translated into Japanese by Japan Clinical Oncology Group Jpn J Cancer Chemother 28 1993 2027
22. P Therasse SG Arbuck EA Eisenhauer 2000 New guidlines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205 216
23. Japanese Society for Esophageal Diseases 1992 Guidelines for the clinical and pathologic studies on carcinoma of the esophagus (8th edn) Kanehara Syuppan Tokyo
24. T Yoshioka M Gamoh R Shineha 1999 A new combination chemotherapy with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for advanced esophageal cancers Internal Medicine 38 844 848
25. K Muro K Shirao Y Shimada 1999 A phase I-II study of nedaplatin and 5-fluorouracil in patients with advanced esophageal cancer Proc ASCO 18 258a
26. S Shibata H Kawasaki M Nakai 2002 Chemoradiotherapy using platinum analogs/5-FU for advanced esophageal cancer Jpn J Cancer Chemother 29 2209 2212
27. T Nakamura H Ide R Eguchi 2003 Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer Jpn J Chemoter 30 803 807
28. K Nemoto H Matsushita Y Ogawa 2003 Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer Am J Clin Oncol 26 46 49
29. H Kato M Fukuchi R Manda 2003 Efficacy and toxicity of nedaplatin and 5-FU with radiation for advanced esophageal carcinomas Anticancer Res 23 3493 3498
30. H Kobayashi Y Takemura H Miyachi T Ogawa 1991 Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatin Invest New Drugs 9 313 319
31. M Fukuda Y Ohe F Kanazawa 1995 Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin Anticancer Res 15 393 398
32. DS Alberts PT Fanta KL Running 1997 In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers Cancer Chemother Pharmacol 39 493 497
33. BJ Monk DS Alberts RA Burger 1998 In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers Gynecol Oncol 71 308 312